Insights, clinical perspective, and honest conversation from the MedBridge Global faculty - on peptides, regenerative medicine, and practicing at the standard the science deserves.
A hospitalisation after a gray-market sermorelin injection, contaminated samples and FDA warning letters: a summary of the latest concerns about unregulated peptides, and what they mean for clinicians.
ACOG has published its most comprehensive menopause guidance to date, covering hot flashes, night sweats, sleep and mood. A summary of what changed for clinicians, with links to the source.
The FDA convened a workshop on testosterone therapy in menopausal women, where one UK clinic's real-world data took center stage. Here's what clinicians should take from it.
Nate Hill of Strive Pharmacy on FDA Category 1, GMP-vetted API sourcing, and how compounding pharmacies are preparing for the next phase of peptide regulation.
On bandwagons, MLM energy, "not for human use" experts, and the incredibly powerful science that deserves better than what social media is doing to it.